Article
Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents
21 Nov 2007
Abstract excerpt
Treatment resistance, whether inherent or acquired, is a major problem reducing the activity of conventional and newer, molecularly targeted, cancer drugs. A more complex picture of the causes and contributions of specific forms of resistance is now emerging through application of pharmacological, proteomic and gene expression technologies and we have entered an exciting time where new molecular research tools...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
